Literature DB >> 11379672

Is ventilator-associated pneumonia an independent risk factor for death?

F Bregeon1, V Ciais, V Carret, R Gregoire, P Saux, M Gainnier, X Thirion, M Drancourt, J P Auffray, L Papazian.   

Abstract

BACKGROUND: Ventilator-associated pneumonia (VAP) has been implicitly accused of increasing mortality. However, it is not certain that pneumonia is responsible for death or whether fatal outcome is caused by other risk factors for death that exist before the onset of pneumonia. The aim of this study was to evaluate the attributable mortality caused by VAP by performing a matched-paired, case-control study between patients who died and patients who were discharged from the intensive care unit after more than 48 h of mechanical ventilation.
METHODS: During the study period, 135 consecutive deaths were included in the case group. Case-control matching criteria were as follows: (1) diagnosis on admission that corresponded to 1 of 11 predefined diagnostic groups; (2) age difference within 10 yr; (3) sex; (4) admission within 1 yr; (5) APACHE II score within 7 points; (6) ventilation of control patients for at least as long as the cases. Precise clinical, radiologic, and microbiologic definitions were used to identify VAP.
RESULTS: Analysis was performed on 108 pairs that were matched with 91% of success. There were 39 patients (36.1%) who developed VAP in each group. Multivariate analysis showed that renal failure, bone marrow failure, and treatment with corticosteroids but not VAP were independent risk factors for death. There was no difference observed between cases and controls concerning the clinical and microbiologic diagnostic criteria for pneumonia.
CONCLUSION: Ventilator-associated pneumonia does not appear to be an independent risk factor for death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379672     DOI: 10.1097/00000542-200104000-00005

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  10 in total

1.  Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution.

Authors:  Sujata M Bhavnani; Jeffrey P Hammel; Elizabeth A Lakota; M Courtney Safir; Brian D VanScoy; Yu Nagira; Christopher M Rubino; Nobuo Sato; Tomokazu Koresawa; Kenichiro Kondo; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.

Authors:  Boris Jung; Nathalie Embriaco; François Roux; Jean-Marie Forel; Didier Demory; Jérôme Allardet-Servent; Samir Jaber; Bernard La Scola; Laurent Papazian
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

3.  Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.

Authors:  Hannah R Rose; Robert S Holzman; Deena R Altman; Davida S Smyth; Gregory A Wasserman; Jared M Kafer; Michelle Wible; Rodrigo E Mendes; Victor J Torres; Bo Shopsin
Journal:  J Infect Dis       Date:  2014-10-07       Impact factor: 5.226

Review 4.  Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients.

Authors:  George Tokmaji; Hester Vermeulen; Marcella C A Müller; Paulus H S Kwakman; Marcus J Schultz; Sebastian A J Zaat
Journal:  Cochrane Database Syst Rev       Date:  2015-08-12

5.  Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy.

Authors:  Jean-Marie Forel; François Voillet; Daniel Pulina; Arnaud Gacouin; Gilles Perrin; Karine Barrau; Samir Jaber; Jean-Michel Arnal; Mohamed Fathallah; Pascal Auquier; Antoine Roch; Elie Azoulay; Laurent Papazian
Journal:  Crit Care       Date:  2012-12-12       Impact factor: 9.097

6.  Intensive care acquired infection is an independent risk factor for hospital mortality: a prospective cohort study.

Authors:  Pekka Ylipalosaari; Tero I Ala-Kokko; Jouko Laurila; Pasi Ohtonen; Hannu Syrjälä
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  Ventilator-associated pneumonia among elderly Medicare beneficiaries in long-term care hospitals.

Authors:  William Buczko
Journal:  Health Care Financ Rev       Date:  2010

Review 8.  Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis.

Authors:  Yating Li; Chenxia Liu; Wei Xiao; Tiantian Song; Shuhui Wang
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

9.  Epidemiology of Intensive Care Unit-acquired Infections in a Tertiary Care Hospital of North India.

Authors:  Amit Kumar; Dhruva Chaudhry; Nidhi Goel; Shweta Tanwar
Journal:  Indian J Crit Care Med       Date:  2021-12

Review 10.  Probiotics for preventing ventilator-associated pneumonia: a systematic review and meta-analysis of high-quality randomized controlled trials.

Authors:  Jie Wang; Kai-xiong Liu; Felinda Ariani; Li-Li Tao; Jing Zhang; Jie-Ming Qu
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.